BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8127350)

  • 1. Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine.
    Trendle MC; Tefferi A
    N Engl J Med; 1994 Apr; 330(15):1090. PubMed ID: 8127350
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
    Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
    Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
    [No Abstract]   [Full Text] [Related]  

  • 4. Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia.
    Dann EJ; Gillis S; Polliack A; Okon E; Rund D; Rachmilewitz EA
    N Engl J Med; 1993 Nov; 329(21):1547-8. PubMed ID: 8105383
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
    Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
    J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 7. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peliosis hepatis after treatment with 2-chloro-3'-deoxyadenosine.
    Gushiken FC
    South Med J; 2000 Jun; 93(6):625-6. PubMed ID: 10881786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.
    Carrera CJ; Piro LD; Saven A; Beutler E; Terai C; Carson DA
    Adv Exp Med Biol; 1991; 309A():15-8. PubMed ID: 1686349
    [No Abstract]   [Full Text] [Related]  

  • 11. 2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells.
    Gora-Tybor J; Lech-Miranda E; Blonski JZ; Robak T
    Adv Exp Med Biol; 2000; 486():307-10. PubMed ID: 11783506
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G; Elmhorn-Rosenborg A; Liliemark J
    N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases.
    Robak T; Błasińska-Morawiec M; Krykowski E; Hellmann A; Lewandowski K; Dmoszyńska A; Adamczyk-Cioch M; Kazimierczak M; Trepińska E; Dwilewicz-Trojaczek M; Kuratowska Z; Skotnicki AB; Nowak WS; Zdziarska B; Urasiński I
    Eur J Haematol; 1997 Oct; 59(4):216-20. PubMed ID: 9338619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids.
    Coutinho AK; de O Santos M; Pinczowski H; Feher O; del Giglio A
    Am J Hematol; 1997 Jan; 54(1):85-6. PubMed ID: 8980269
    [No Abstract]   [Full Text] [Related]  

  • 15. Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia.
    Kaur V; Mehta P; Johnsurd J; Govindarajan R
    Blood; 2014 Nov; 124(23):3503-5. PubMed ID: 25431479
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
    Moutouh-de Parseval LA; Weiss L; DeLap RJ; Knight RD; Zeldis JB
    J Clin Oncol; 2007 Nov; 25(31):5047. PubMed ID: 17971612
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
    List AF; Kummet TD; Adams JD; Chun HG
    Am J Med; 1990 Sep; 89(3):388-90. PubMed ID: 1697447
    [No Abstract]   [Full Text] [Related]  

  • 18. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
    Frame JN; Dahut WL; Crowley S
    N Engl J Med; 1992 Nov; 327(19):1396-7. PubMed ID: 1406856
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
    Mulligan SP; Dean MG
    Aust N Z J Med; 1994 Aug; 24(4):406-7. PubMed ID: 7980241
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
    Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.